Abstract A 5 year old boy presented with obstruction of the pulmonary venous pathway four years after the Mustard procedure. A successful balloon dilatation of the pulmonary venous pathway was performed but the benefit was transient. Placement of a 10 mm balloon expandable intravascular stent across the recurrent stenosis resulted in complete relief of the obstruction with prompt resolution of the clinical signs. The delivery system was modified to facilitate stent delivery. (Br Heart 1994;72:85-88) Paediatric experience with transcatheter placement of endovascular stents for residual stenosis has expanded from the initial studies of systemic vein and pulmonary artery dilatation to include recent reports of stenting of the ductus arteriosus, aortopulmonary collaterals, and postoperative coarctation of the aorta.' 2 After the Mustard operation for transposition of the great arteries, pulmonary venous pathway obstruction is a less common but more severe complication than systemic venous pathway obstruction.3 In an attempt to avoid surgery with its attendant high operative risks balloon dilatation has shown some benefit, although restenosis often occurs. 4 We report the successful percutaneous intravascular stenting of recurrent pulmonary venous pathway obstruction after a previously successful balloon dilatation. We discuss the technical modifications found useful in facilitating stent placement in locations with difficult access.
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Before stenting, both angiography and transoesophageal echocardiography showed a discrete wedge of tissue projecting into the venous channel from the superior atrial wall resulting in a minimal pulmonary channel of 4 mm (fig 2A) . Haemodynamic measurements showed a mean gradient of 12 mm Hg, with a maximal Doppler velocity of 1-9 m/s and non-laminar colour flow Doppler. After stent placement indwelling transoesophageal echocardiography clearly showed the stent in an optimal position with a widely patent lumen of 10 mm diameter and laminar unobstructed colour flow Doppler across the open stent (maximal velocity of 0-8 m/s). To avoid potentially dislodging the stent a pressure catheter was not placed across the area and the wire and catheters were removed without complication. The patient was maintained on a heparin infusion (20 U/kglh) for 24 hours then subsequently placed on aspirin (8 mg/kg/day).
Since the procedure a dramatic clinical improvement has been seen. His chest x ray film has cleared, there is no further need for diuretic treatment, and oxygen saturations are above 95% in room air. His activity level and general demeanour have dramatically 
Discussion
In t-his report we describe the successful application of percutaneous intravascular stenting for the treatment of a persistent pulmonary venous pathway obstruction. Balloon dilatation of a pulmonary venous pathway obstruction has been shown to be an efficacious therapeutic option for this difficult complication of both the Mustard and Senning repair. There is, however, a strong tendency for the stenosis to reoccur4 and these patients present a high risk at reoperation.3 Intraluminal stents, when inflated, expand with a high resistance to radial collapse thus making them optimal devices for maintaining patency across the distensible venous baffle. One consideration in whether to stent for baffle obstruction is the length of contact between the baffle and the superior atrial wall. This should be sufficient to allow the stent to have adequate atrial wall to baffle contact so as to maintain a stable position when inflated. Care must be made to ensure that, when positioning the stent, the origin of the right upper and right lower pulmonary veins will not be distorted on inflation (fig 1(A) ), which could induce a pulmonary vein stenosis. In this case, placement of the stent across the area of restenosis resulted in a widely patent 10 mm channel with no evidence of stenosis by both imaging and Doppler colour flow mapping. This was associated with a considerable clinical improvement, although close follow-up will be required. As the stent is within the systemic circulation we have decided to continue antiplatelet treatment indefinitely, rather than the usual six months for devices placed within the pulmonary circuit or systemic veins.
For pulmonary venous pathway balloon dilation, balloon to stenosis ratios of three to four have been recommended. (fig 3) makes it unlikely that this would contribute to restenosis.
Due to the tortuous route required to position the stent across the baffle stenosis and as a result of previous experience, we have modified the placement technique from that previously described. In previously described reports after the sheath and dilator have been positioned across the area of stenosis the dilator catheter is removed leaving the guide wire and empty sheath in place.' On removal of the dilator catheter there is a tendency to develop kinks within the sheath especially in those cases where the catheter is needed to negotiate acute angles. As a result, when attempting to pass the balloon dilatation or stent catheter through the sheath it can become caught in the kink, causing displacement of the stent from the balloon. Alternatively, the stent may be unable to traverse the kink thus necessitating the replacement of the dilator and further catheter manipulations to straighten out the delivery sheath. With the stent delivery catheter as part of the sheath and manoeuvring the entire complex as a unit obviates the development of the sheath kinks. This greatly eases stent placement in small infants and in stenoses with difficult access. As the sheath does not require flushing this is especially advantageous for cases needing stent placement in the systemic circulation.
In conclusion, this case shows that persistent obstruction of the pulmonary venous outlet can be successfully relieved with the use of a percutaneous intravascular stent and further expands the paediatric applications of this new therapeutic method. The long term patency of such a device within the pulmonary venous system remains unknown, although large diameter stents in high flow venous channels have previously shown optimal patency rates. 6 The modifications of the delivery technique that we described have facilitated the technical aspects of stent placement.
